Company Filing History:
Years Active: 1999
Title: Thomas G Eckhardt: Innovator in Vaccine Development
Introduction
Thomas G Eckhardt is a notable inventor based in New Windsor, NY (US). He has made significant contributions to the field of vaccine development, particularly in creating efficacious vaccines against Bordetella pertussis. With a total of four patents to his name, Eckhardt's work has the potential to impact public health positively.
Latest Patents
Eckhardt's latest patents focus on innovative vaccines for the prevention of diseases caused by Bordetella pertussis. These vaccines comprise pertussis antigens such as filamentous hemagglutinin, detoxified lymphocytosis promoting factor, and a 69 kilodalton outer membrane protein. The unique aspect of his invention is that these antigens are individually purified before being combined to form the vaccine. This method allows for the creation of pertussis vaccines where the antigens can be combined in various ratios, including those not achievable with whole cell or co-purified acellular pertussis vaccines. Furthermore, the pertussis antigens may be combined with other individually purified components, adjuvants, stabilizers, and non-pertussis vaccine elements.
Career Highlights
Eckhardt has been associated with the American Cyanamid Company, where he has contributed to groundbreaking research and development in vaccine technology. His work has been instrumental in advancing the understanding and prevention of pertussis, a disease that poses significant health risks, especially to children.
Collaborations
Throughout his career, Eckhardt has collaborated with esteemed colleagues such as John W Gotto and David K McClintock. These collaborations have fostered an environment of innovation and have led to the successful development of new vaccine technologies.
Conclusion
Thomas G Eckhardt's contributions to vaccine development, particularly against Bordetella pertussis, highlight his role as a significant inventor in the field. His innovative approaches and collaborations continue to pave the way for advancements in public health.